Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Delayed Quote USD

USANA Health Sciences, Inc. (USNA)

Compare
27.26
+0.29
+(1.08%)
At close: 4:00:02 PM EDT
27.36
+0.10
+(0.37%)
After hours: 5:00:48 PM EDT
Loading Chart for USNA
  • Previous Close 26.97
  • Open 26.58
  • Bid 26.00 x 800
  • Ask 28.60 x 1000
  • Day's Range 26.40 - 27.33
  • 52 Week Range 26.19 - 49.78
  • Volume 157,692
  • Avg. Volume 192,710
  • Market Cap (intraday) 515.337M
  • Beta (5Y Monthly) 0.98
  • PE Ratio (TTM) 12.45
  • EPS (TTM) 2.19
  • Earnings Date Apr 28, 2025 - May 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 50.50

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It also provides Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

www.usana.com

1,700

Full Time Employees

December 28

Fiscal Year Ends

Recent News: USNA

View More

Performance Overview: USNA

Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

USNA
24.05%
S&P 500 (^GSPC)
4.23%

1-Year Return

USNA
43.16%
S&P 500 (^GSPC)
7.42%

3-Year Return

USNA
65.64%
S&P 500 (^GSPC)
23.92%

5-Year Return

USNA
50.70%
S&P 500 (^GSPC)
128.01%

Compare To: USNA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: USNA

View More

Valuation Measures

Annual
As of 3/31/2025
  • Market Cap

    509.86M

  • Enterprise Value

    357.10M

  • Trailing P/E

    12.32

  • Forward P/E

    9.80

  • PEG Ratio (5yr expected)

    0.82

  • Price/Sales (ttm)

    0.60

  • Price/Book (mrq)

    0.96

  • Enterprise Value/Revenue

    0.42

  • Enterprise Value/EBITDA

    3.61

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.92%

  • Return on Assets (ttm)

    6.00%

  • Return on Equity (ttm)

    7.76%

  • Revenue (ttm)

    854.5M

  • Net Income Avi to Common (ttm)

    42.03M

  • Diluted EPS (ttm)

    2.19

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    181.77M

  • Total Debt/Equity (mrq)

    6.69%

  • Levered Free Cash Flow (ttm)

    57.95M

Research Analysis: USNA

View More

Company Insights: USNA

Research Reports: USNA

View More

People Also Watch